"# ALX Oncology Holdings Inc. увидела значительное изменение в своей структуре руководства недавно, с Шелли Вонг, senior vice president of finance и chief accounting officer, продав $1,105 стоимости компании акций на 17 августа 2026 года. Следовательно, Вонг напрямую владеет 87,828 акциями ALX Oncology Holdings Inc. общего акционерного капитала.
Кंपनия также объявила о назначении Скотта Гардинга новым председателем совета директоров, с efectivnoy immediately. Гардинг succeeds co-founder Corey Goodman, who is stepping down after more than ten years with the company. Additionally, Michael Listgarten has been named as the new General Counsel. Гардинг has been a member of the ALX Oncology Board since November 2022 and brings over 30 years of experience in the biopharmaceutical industry.
These developments mark a notable shift in the company’s governance structure, as Garland and Listgarten bring industry expertise to the table. Wong, who has been with the company since its inception, will continue to play a key role in its financial and accounting functions.
Контрольная структура реформирована
Изменения в руководстве пришли как к ALX Oncology Holdings Inc. продолжает navigate complexities of biopharmaceutical industry. With Garland and Listgarten at helm, company is well-positioned to drive growth and innovation in coming years.
Ключевые игроки
- Shelly Wong: Senior Vice President of Finance and Chief Accounting Officer
- Scott Garland: Chairman of the Board of Directors
- Corey Goodman: Former Chairman of the Board of Directors
- Michael Listgarten: General Counsel